CIPN |
Chemotherapy-induced Peripheral Neuropathy |
ALL |
Acute Lymphoblastic Leukemia |
PT |
Physical Therapy |
PRISMA |
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses |
RCT |
Randomized Controlled Trial |
CCT |
Controlled Clinical Trial |
EORTC |
European Organization for Research and Treatment of
Cancer |
QLQ-CIPN20 |
Quality of Life Questionnaire-CIPN twenty-item
scale |
ped-mTNS |
Pediatric Modified Total Peripheral Neuropathy
Score |
TNS-PV |
Total Neuropathy Score-Pediatric Vincristine |
TNS |
Total Neuropathy Score |
ROM |
Range of Motion |
BOT-2 |
Bruininks Osteretsky Test of Motor Proficiency Second
Edition |
PDMS-2 |
Peabody Developmental Motor Scales |
6-MWT |
6-minute Walk Test |
2-MWT |
2-minute Walk Test |
9-MWT |
9-minute Walk Test |
TUG |
Timed Up and Go Test |
TUDS |
Timed Up and Down Stairs |
FP1-6 |
Foot Posture Index |
VAS |
Visual Analog Scale |
ROB 2 |
Cochrane risk-of-bias tool for randomized trials |
BOTSF-2 |
Bruininks-Oseretsky Test of Motor Proficiency Short
Form |
GMFM-ALL |
Gross Motor Function - Measure-Acute Lymphoblastic Leukemia
Scale |
BSID-II |
Dutch Bayley Scales of Infant Development II |
Movement-ABC |
The Movement Assessment Battery for
Children |
MRC |
Medical Research Council |
PBS |
Pediatric Balance Scale |